- Quinacrine Treatment Of vCJD Patient
- A British woman who became the first human guinea pig
in trials to find a cure for variant Creutzfeldt-Jakob disease [abbreviated
as vCJD or CJD (new var.) in ProMED-mail] has died. The patient's condition
improved dramatically after she received a course of drugs from the Nobel
Prize-winning scientist who discovered the cause of the human form of mad
cow disease. It is thought that the 21-year old woman was taken off the
drug, Quinacrine, after complications set in and affected her liver.
- The former Royal Signals soldier was diagnosed as
vCJD 6 months after she began showing signs of depression last Christmas.
She quickly deteriorated from a happy, active young woman, to a bed-ridden
invalid requiring constant care, who was unable to recognise members of
her family, stand noise or sunlight, or feed and dress herself. Her father
had contacted Professor Stanley Prusiner, who invited her to his San
clinic to become the first human to try Quinacrine.
- From ProMED mail firstname.lastname@example.org
Site Served by TheHostPros